257 related articles for article (PubMed ID: 11375576)
1. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus.
Fass R; Garewal HS; Hayden CW; Ramsey L; Sampliner RE
Gastrointest Endosc; 2001 Jun; 53(7):711-6. PubMed ID: 11375576
[TBL] [Abstract][Full Text] [Related]
2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
3. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
4. Extension of squamous epithelium into the proximal stomach: a newly recognized mucosal abnormality.
Fass R; Sampliner RE
Endoscopy; 2000 Jan; 32(1):27-32. PubMed ID: 10691268
[TBL] [Abstract][Full Text] [Related]
5. Squamous islands in Barrett's esophagus: what lies underneath?
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1998 Mar; 93(3):332-5. PubMed ID: 9517634
[TBL] [Abstract][Full Text] [Related]
6. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus.
Sampliner RE; Camargo L; Fass R
Am J Gastroenterol; 2002 Feb; 97(2):270-2. PubMed ID: 11866260
[TBL] [Abstract][Full Text] [Related]
7. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
[TBL] [Abstract][Full Text] [Related]
8. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
[TBL] [Abstract][Full Text] [Related]
9. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
10. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
[TBL] [Abstract][Full Text] [Related]
11. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
Sampliner RE
Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
[TBL] [Abstract][Full Text] [Related]
12. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.
Lord RV; Wickramasinghe K; Johansson JJ; Demeester SR; Brabender J; Demeester TR
Surgery; 2004 Sep; 136(3):633-40. PubMed ID: 15349112
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.
Dumoulin FL; Terjung B; Neubrand M; Scheurlen C; Fischer HP; Sauerbruch T
Endoscopy; 1997 Oct; 29(8):751-3. PubMed ID: 9427496
[TBL] [Abstract][Full Text] [Related]
14. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
[TBL] [Abstract][Full Text] [Related]
15. Ablation of Barrett's mucosa.
Sampliner RE
Gastroenterologist; 1997 Sep; 5(3):185-8. PubMed ID: 9298373
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of Barrett's esophagus: short-term results.
Eldaif SM; Lin E; Singh KA; Force SD; Miller DL
Ann Thorac Surg; 2009 Feb; 87(2):405-10; discussion 410-1. PubMed ID: 19161747
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
[TBL] [Abstract][Full Text] [Related]
18. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial.
Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1168-73. PubMed ID: 21840549
[TBL] [Abstract][Full Text] [Related]
19. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
20. Balloon-based electrode for the ablation of non-dysplastic Barrett's esophagus: ablation of intestinal metaplasia (AIM II Trial).
Avilés A; Reymunde A; Santiago N
Bol Asoc Med P R; 2006; 98(4):270-5. PubMed ID: 19610568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]